147 related articles for article (PubMed ID: 6218128)
1. Dapsone--other indications.
Barranco VP
Int J Dermatol; 1982 Nov; 21(9):513-4. PubMed ID: 6218128
[No Abstract] [Full Text] [Related]
2. Dapsone for the treatment of vesiculo-bullous and pustular diseases.
Piamphongsant T
Int J Dermatol; 1982 Nov; 21(9):512. PubMed ID: 6218127
[No Abstract] [Full Text] [Related]
3. When and how to use sulfones in bullous diseases.
Jablonska S; Chorzelski T
Int J Dermatol; 1981 Mar; 20(2):103-5. PubMed ID: 7012048
[No Abstract] [Full Text] [Related]
4. Dapsone for the treatment of bullous pemphigoid.
Piamphongsant T
Asian Pac J Allergy Immunol; 1983 Jun; 1(1):19-21. PubMed ID: 6398078
[No Abstract] [Full Text] [Related]
5. The treatment of benign chronic bullous dermatosis of childhood, and dermatitis herpetiformis and bullous pemphigoid beginning in childhood.
Marsden RA
Clin Exp Dermatol; 1982 Nov; 7(6):653-63. PubMed ID: 6758997
[No Abstract] [Full Text] [Related]
6. Sulphamethoxypyridazine for dermatitis herpetiformis, linear IgA disease and cicatricial pemphigoid.
McFadden JP; Leonard JN; Powles AV; Rutman AJ; Fry L
Br J Dermatol; 1989 Dec; 121(6):759-62. PubMed ID: 2692691
[TBL] [Abstract][Full Text] [Related]
7. Dapsone as first line therapy for bullous pemphigoid.
Venning VA; Millard PR; Wojnarowska F
Br J Dermatol; 1989 Jan; 120(1):83-92. PubMed ID: 2700666
[TBL] [Abstract][Full Text] [Related]
8. [Conversion of Duhring's dermatitis herpetiformis into bullous pemphigoid].
Jablonska St
Hautarzt; 1977 Feb; 28(2):114. PubMed ID: 321396
[No Abstract] [Full Text] [Related]
9. Autoimmune bullous dermatoses: a review.
Patrício P; Ferreira C; Gomes MM; Filipe P
Ann N Y Acad Sci; 2009 Sep; 1173():203-10. PubMed ID: 19758152
[TBL] [Abstract][Full Text] [Related]
10. Dapsone and sulfapyridine therapy of pemphigoid diseases.
Rogers RS
Australas J Dermatol; 1986 Aug; 27(2):58-63. PubMed ID: 3555440
[No Abstract] [Full Text] [Related]
11. Adjuvant therapy of bullous pemphigoid with dapsone.
Jeffes EW; Ahmed AR
Clin Exp Dermatol; 1989 Mar; 14(2):132-6. PubMed ID: 2689016
[TBL] [Abstract][Full Text] [Related]
12. Linear IgA dapsone responsive bullous dermatosis.
Wojnarowska F
J R Soc Med; 1980 May; 73(5):371-3. PubMed ID: 7017131
[No Abstract] [Full Text] [Related]
13. Treatment of subepidermal immunobullous diseases.
Wojnarowska F; Kirtschig G; Khumalo N
Clin Dermatol; 2001; 19(6):768-77. PubMed ID: 11705687
[No Abstract] [Full Text] [Related]
14. [Clinical characteristics of herpetiform dermatitis and bullous pemphigoid].
Sheklakova MN
Vestn Dermatol Venerol; 1980 Nov; (11):39-41. PubMed ID: 7003978
[No Abstract] [Full Text] [Related]
15. The autoimmune bullous diseases.
Wakelin SH; Black MM
J R Coll Physicians Lond; 1997; 31(4):364-8. PubMed ID: 9263961
[No Abstract] [Full Text] [Related]
16. IgA dermatosis in an adult Chinese population. A 10-year study of linear IgA and dermatitis herpetiformis in Singapore.
Ratnam KV
Int J Dermatol; 1988; 27(1):21-4. PubMed ID: 3278990
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic experience in pemphigus and pemphigoid].
Aloi FG; Pippione M
G Ital Dermatol Venereol; 1984; 119(5):357-64. PubMed ID: 6392076
[No Abstract] [Full Text] [Related]
18. Blistering diseases in the mature patient.
Lakoš Jukić I; Jerković Gulin S; Marinović B
Clin Dermatol; 2018; 36(2):231-238. PubMed ID: 29566927
[TBL] [Abstract][Full Text] [Related]
19. Update on the use of dapsone in dermatology.
Ghaoui N; Hanna E; Abbas O; Kibbi AG; Kurban M
Int J Dermatol; 2020 Jul; 59(7):787-795. PubMed ID: 31909480
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic use of dapsone in dermatitis herpetiformis (Duhring) and in certain inflammatory skin diseases].
Révész K; Schneider I
Orv Hetil; 1995 Jan; 136(2):59-62. PubMed ID: 7862431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
